BioPorto A/S (FRA:2P4)
0.1422
0.00 (0.00%)
At close: Dec 4, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
| Neutrophil Gelatinase-associated Lipocalin Tests | 23.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neutrophil Gelatinase-associated Lipocalin Tests Growth | 24.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibodies | 10.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibodies Growth | 0.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enzyme-linked Immunosorbent Assay Kits | 2.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enzyme-linked Immunosorbent Assay Kits Growth | 35.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty and Other | 137.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Royalty and Other Growth | 204.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Products and Licenses | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Products and Licenses Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
| United States | 20.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 18.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 10.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 5.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 5.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 42.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 134.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | -25.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regions | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|